Cargando…

1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age

Detalles Bibliográficos
Autores principales: Gorse, Geoffrey J., Falsey, Ann, Landolfi, Victoria, Ozol-Godfrey, Ayca, Tsang, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781631/
http://dx.doi.org/10.1093/ofid/ofu052.762
_version_ 1783295001118113792
author Gorse, Geoffrey J.
Falsey, Ann
Landolfi, Victoria
Ozol-Godfrey, Ayca
Tsang, Peter
author_facet Gorse, Geoffrey J.
Falsey, Ann
Landolfi, Victoria
Ozol-Godfrey, Ayca
Tsang, Peter
author_sort Gorse, Geoffrey J.
collection PubMed
description
format Online
Article
Text
id pubmed-5781631
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57816312018-03-01 1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age Gorse, Geoffrey J. Falsey, Ann Landolfi, Victoria Ozol-Godfrey, Ayca Tsang, Peter Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781631/ http://dx.doi.org/10.1093/ofid/ofu052.762 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Gorse, Geoffrey J.
Falsey, Ann
Landolfi, Victoria
Ozol-Godfrey, Ayca
Tsang, Peter
1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
title 1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
title_full 1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
title_fullStr 1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
title_full_unstemmed 1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
title_short 1054 Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age
title_sort 1054 immunogenicity and safety of quadrivalent influenza vaccine administered intradermally (id) in adults 18 through 64 years of age
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781631/
http://dx.doi.org/10.1093/ofid/ofu052.762
work_keys_str_mv AT gorsegeoffreyj 1054immunogenicityandsafetyofquadrivalentinfluenzavaccineadministeredintradermallyidinadults18through64yearsofage
AT falseyann 1054immunogenicityandsafetyofquadrivalentinfluenzavaccineadministeredintradermallyidinadults18through64yearsofage
AT landolfivictoria 1054immunogenicityandsafetyofquadrivalentinfluenzavaccineadministeredintradermallyidinadults18through64yearsofage
AT ozolgodfreyayca 1054immunogenicityandsafetyofquadrivalentinfluenzavaccineadministeredintradermallyidinadults18through64yearsofage
AT tsangpeter 1054immunogenicityandsafetyofquadrivalentinfluenzavaccineadministeredintradermallyidinadults18through64yearsofage